Unknown PHASE3 INTERVENTIONAL 2-arm NCT03044184

Tranexamic Acid for Spontaneous Acute Cerebral Hemorrhage Trial (TRANSACT)

Randomized, Double-blind, Placebo-controlled Trial to Investigate the Effectiveness of Early Intravenous Tranexamic Acid in Limiting Hematoma Expansion in Patients With Spontaneous Intracerebral Hemorrhage

Sponsor: Kwong Wah Hospital

Conditions Intracerebral Haemorrhage Stroke Hemorrhagic

Interventions Tranexamic Acid

Updated 7 times since 2017 Last updated: Oct 15, 2019 Started: Apr 1, 2017 Primary completion: Jun 30, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Intracerebral Haemorrhage and Stroke Hemorrhagic and is currently ongoing. Kwong Wah Hospital leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Nov 2021 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2021 [monthly]

Recruiting PHASE3
Nov 2019 — Jan 2021 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

Jun 2018 — Nov 2019 [monthly]

Not Yet Recruiting PHASE3
Feb 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kwong Wah Hospital

Data source: Kwong Wah Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong